A large proportion of cutaneous melanomas harbor mutations in genes that are part of the mitogen activated protein kinase (MAPK) pathway (i.e., BRAF and NRAS), which deregulate several important biological processes (proliferation, senescence, survival, and differentiation) in melanocytes. This evidence concerns the gene NRAS and cutaneous melanoma.